# VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis

> **NCT00314990** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 620 (—)

## Conditions studied

- Deep-Vein Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin

## Key facts

- **NCT ID:** NCT00314990
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** —
- **Final completion:** 2003-01
- **Target enrollment:** 620 (—)
- **Last updated:** 2006-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314990, "VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00314990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*